Home › Therapeutic areas › Infectious Disease › COVID-19

COVID-19 (4 companies)

Companies with an active program in COVID-19.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CAPR Capricor Therapeutics Infectious DiseaseNeurology Rare 1 NDA Submitted $489M 2
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 1 Approved $253M 8
IVVD Invivyd Infectious Disease 3 Approved $152M 5
OCGN Ocugen Infectious DiseaseOphthalmology Rare 2 Phase 3 $257M 12